Rationale for the use of nonabsorbable antibiotics to treat urinary infections: preliminary clinical report.
D000813:Anilides / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D002908:Chronic Disease; D004927:Escherichia coli Infections / Q000188:drug therapy; D005243:Feces / Q000032:analysis; D006801:Humans; D007408:Intestinal Absorption; D007710:Klebsiella Infections / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013432:Sulfathiazoles / Q000627:therapeutic use*; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy*; D014556:Urine / Q000032:analysis
D000813:Anilides; D000892:Anti-Infective Agents, Urinary; D013432:Sulfathiazoles